Atrius Health Central OB/GYN CME Presents: OB/GYN Clinical Educational Meeting, 10/19/22
Claiming Credit for Session
Thank you for attending Atrius Health's OB/GYN Clinical Meeting on October 19, 2022. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.
Educational Needs Addressed
In this meeting, Atrius Health discussed the new advances in guidelines and treatments as identified by their internal specialists and CME planning committee. The latest practice data and findings were discussed with the goal of further improving internal practice and treatments.
Atrius Health OB/GYN Clinicians
At the completion of this activity, pharmacists will be able to:
- Comply with SMFM guidelines for management of cholestasis of pregnancy
- Practice aligned with up-to-date COVID evidence and guidelines
- Implement strategies to increase vaccination (flu shot acceptance)
- Understand diagnosis and implications of placenta accreta
- Discuss definition, implications of bioidentical HT including testosterone
- Appreciate the status and implications of recent abortion legislation for women’s health
- Optimize use of laboratory tests of the vagina
- Align personal practice with departmental and organizational goals
Faculty Presenters and Disclosures
Martha Richardson, MD
Obstetrics and Gynecology
Harvard Vanguard Medical Associates
The Copley Center
Rebecca Hart-Holder; David Kindelberger, MD; Payal Srinivasa, MD; Mary Vadnais, MD; Martha Richardson, MD and Kevin Fitzpatrick, MD of Atrius Health have no relevant financial relationships to disclose.
Scott Shainkar, DO, MS discloses he receives grant/research support from the Chase Koch Foundation, the Charles Koch Foundtaion, and is a consultant for Health Advances and Reckner Inc.
Dr. Richardson will discuss the unlabeled/investigational use of testosterone and progesterone.
Planning Committee and Disclosures
Meghan Bride, NP; Erin Brooks, MD, Caroline Elich, RN; Deborah Platek, MD; Martha Richardson, MD; and Payal Srinivasas, MD, of Atrius Health have no relevant financial relationships to disclose.
The following planning committee members from Boston University School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships to disclose:
Michael Burk, BS – Operations Manager
Carmela A. Townsend, DNP, MS/MBA, RN – Lead Nurse Planner
Accreditor Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Atrius Health. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly-provided by Atrius Health.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Contact Hours: 3.25, of which 1 is eligible for pharmacology credit
- 0.00 ACPE Pharmacy
- 3.25 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 3.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.25 ANCC
- 1.00 ANCC Pharmacology
- 3.25 Participation